Literature DB >> 24023493

Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1.

Atsushi Iraha1, Hiroshi Chinen, Akira Hokama, Takumi Yonashiro, Tetsu Kinjo, Kazuto Kishimoto, Manabu Nakamoto, Tetsuo Hirata, Nagisa Kinjo, Futoshi Higa, Masao Tateyama, Fukunori Kinjo, Jiro Fujita.   

Abstract

AIM: To evaluate the protective effects of fucoidan on oxidative stress-induced barrier disruption in human intestinal epithelial cells.
METHODS: In Caco-2 cell monolayer models, the disruption of barrier function by oxidative stress is mediated by H₂O₂. The integrity of polarized Caco-2 cell monolayers was determined by measuring the transepithelial resistance (TER) and permeability was estimated by measuring the paracellular transport of FITC-labeled 4-kDa dextran (FD4). The protective effects of fucoidan on epithelial barrier functions on polarized Caco-2 cell monolayers were evaluated by TER and FD4 flux. The expression of tight junction (TJ) proteins was assessed using reverse-transcription polymerase chain reaction (RT-PCR) and immunofluorescence staining.
RESULTS: Without H₂O₂ treatment, fucoidan significantly increased the TER compared to control (P < 0.05), indicating a direct enhancement of intestinal epithelial barrier function. Next, H₂O₂ disrupted the epithelial barrier function in a time-dependent manner. Fucoidan prevented the H₂O₂-induced destruction in a dose-dependent manner. Fucoidan significantly decreased H₂O₂-induced FD4 flux (P < 0.01), indicating the prevention of disruption in paracellular permeability. RT-PCR showed that Caco-2 cells endogenously expressed claudin-1 and -2, and occludin and that H₂O₂ reduced the mRNA expression of these TJ proteins. Treatment with fucoidan attenuated the reduction in the expressions of claudin-1 and claudin-2 but not occludin. Immunofluorescence staining revealed that the expression of claudin-1 was intact and high on the cell surface. H₂O₂ disrupted the integrity of claudin-1. Treatment with fucoidan dramatically attenuated the expression of claudin-1.
CONCLUSION: Fucoidan enhanced intestinal epithelial barrier function by upregulating the expression of claudin-1. Thus, fucoidan may be an appropriate therapy for the treatment of inflammatory bowel diseases.

Entities:  

Keywords:  Fucoidan; Inflammatory bowel diseases; Intestinal epithelial cells; Oxidative stress; Tight junction

Mesh:

Substances:

Year:  2013        PMID: 24023493      PMCID: PMC3761103          DOI: 10.3748/wjg.v19.i33.5500

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.

Authors:  T Kucharzik; S V Walsh; J Chen; C A Parkos; A Nusrat
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 2.  Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation.

Authors:  J Berkes; V K Viswanathan; S D Savkovic; G Hecht
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

3.  Claudins regulate the intestinal barrier in response to immune mediators.

Authors:  T Kinugasa; T Sakaguchi; X Gu; H C Reinecker
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

4.  Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms.

Authors:  Matthias Bruewer; Andreas Luegering; Torsten Kucharzik; Charles A Parkos; James L Madara; Ann M Hopkins; Asma Nusrat
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

5.  Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription.

Authors:  Hong-Bo Wang; Peng-Yuan Wang; Xin Wang; Yuan-Lian Wan; Yu-Cun Liu
Journal:  Dig Dis Sci       Date:  2012-06-09       Impact factor: 3.199

6.  Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells.

Authors:  Monica Rimoldi; Marcello Chieppa; Valentina Salucci; Francesca Avogadri; Angelica Sonzogni; Gianluca M Sampietro; Angelo Nespoli; Giuseppe Viale; Paola Allavena; Maria Rescigno
Journal:  Nat Immunol       Date:  2005-04-10       Impact factor: 25.606

7.  Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.

Authors:  Frank Heller; Peter Florian; Christian Bojarski; Jan Richter; Melanie Christ; Bernd Hillenbrand; Joachim Mankertz; Alfred H Gitter; Nataly Bürgel; Michael Fromm; Martin Zeitz; Ivan Fuss; Warren Strober; Jörg D Schulzke
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

8.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.

Authors:  I J Hidalgo; T J Raub; R T Borchardt
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

9.  Glutamine supports recovery from loss of transepithelial resistance and increase of permeability induced by media change in Caco-2 cells.

Authors:  Nan Li; Vincent G DeMarco; Christopher M West; Josef Neu
Journal:  J Nutr Biochem       Date:  2003-07       Impact factor: 6.048

10.  Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells.

Authors:  S Matsumoto; M Nagaoka; T Hara; I Kimura-Takagi; K Mistuyama; S Ueyama
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

View more
  19 in total

1.  Homoectoine Protects Against Colitis by Preventing a Claudin Switch in Epithelial Tight Junctions.

Authors:  Karla F Castro-Ochoa; Hilda Vargas-Robles; Sandra Chánez-Paredes; Alfonso Felipe-López; Rodolfo I Cabrera-Silva; Mineko Shibayama; Abigail Betanzos; Porfirio Nava; Erwin A Galinski; Michael Schnoor
Journal:  Dig Dis Sci       Date:  2018-09-29       Impact factor: 3.199

2.  Immunostimulatory Effect of Enzyme-Modified Hizikia fusiformein a Mouse Model In Vitro and Ex Vivo.

Authors:  Sang-Yong Park; Eunson Hwang; Yu-Kyong Shin; Don-Gil Lee; Jung-Eun Yang; Jae-Hee Park; Tae-Hoo Yi
Journal:  Mar Biotechnol (NY)       Date:  2017-01-30       Impact factor: 3.619

3.  Cystine reduces tight junction permeability and intestinal inflammation induced by oxidative stress in Caco-2 cells.

Authors:  Tatsuya Hasegawa; Ami Mizugaki; Yoshiko Inoue; Hiroyuki Kato; Hitoshi Murakami
Journal:  Amino Acids       Date:  2021-05-15       Impact factor: 3.520

4.  Fucoidan Modulated Oxidative Stress and Caspase-3 mRNA Expression Induced by Sulfoxaflor in the Brain of Mice.

Authors:  Petek Piner Benli; Merve Kaya; Cagil Coskun
Journal:  Neurotox Res       Date:  2021-09-27       Impact factor: 3.911

5.  Delivery of berberine using chitosan/fucoidan-taurine conjugate nanoparticles for treatment of defective intestinal epithelial tight junction barrier.

Authors:  Shao-Jung Wu; Trong-Ming Don; Cheng-Wei Lin; Fwu-Long Mi
Journal:  Mar Drugs       Date:  2014-11-24       Impact factor: 5.118

6.  Low-molecular-weight fucoidan and high-stability fucoxanthin from brown seaweed exert prebiotics and anti-inflammatory activities in Caco-2 cells.

Authors:  Pai-An Hwang; Nam Nhut Phan; Wen-Jung Lu; Bui Thi Ngoc Hieu; Yen-Chang Lin
Journal:  Food Nutr Res       Date:  2016-08-02       Impact factor: 3.894

7.  Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK.

Authors:  Ya-Jing Feng; Yong-Yu Li; Xu-Hong Lin; Kun Li; Ming-Hua Cao
Journal:  World J Gastroenterol       Date:  2016-11-21       Impact factor: 5.742

Review 8.  Therapies from Fucoidan: An Update.

Authors:  Janet Helen Fitton; Damien N Stringer; Samuel S Karpiniec
Journal:  Mar Drugs       Date:  2015-09-16       Impact factor: 5.118

9.  Titanium dioxide nanoparticle impact and translocation through ex vivo, in vivo and in vitro gut epithelia.

Authors:  Emilie Brun; Frédérick Barreau; Giulia Veronesi; Barbara Fayard; Stéphanie Sorieul; Corinne Chanéac; Christine Carapito; Thierry Rabilloud; Aloïse Mabondzo; Nathalie Herlin-Boime; Marie Carrière
Journal:  Part Fibre Toxicol       Date:  2014-03-25       Impact factor: 9.400

Review 10.  Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis.

Authors:  Alexa Klettner
Journal:  Mar Drugs       Date:  2016-02-03       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.